"Indago Research and Health Center is a dedicated Multi-Specialty 8-bed Early Phase/Phase I through Phase IV Clinical Research Center located in Hialeah, Florida. Our facility is a 7,800 square foot Site that houses our administrative, outpatient, and state-of-the-art Early Phase/Phase I accommodations."

During the past decade, Indago Research & Health Center, Inc conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 32 clinical trials were completed, i.e. on average, 48.5% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 29 clinical trials were completed. i.e. 87.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indago Research & Health Center, Inc" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "BioNTech SE" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Merck Sharp & Dohme LLC" with 4 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indago Research & Health Center, Inc" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator and "DSM Nutritional Products, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Indago Research & Health Center, Inc" are "Alzheimer Disease" (8 trials), "COVID-19" (6 trials), "SARS-CoV-2 Infection" (5 trials), "Pneumococcal Disease" (4 trials) and "Severe Hypertriglyceridemia" (3 trials). Many other conditions were trialed in "Indago Research & Health Center, Inc" in a lesser frequency.

Most popular intervention types in "Indago Research & Health Center, Inc" are "Drug" (50 trials), "Biological" (15 trials), "Other" (10 trials), "Combination Product" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "BNT162b2" (5 trials), "BI 685509" (3 trials), "200mg SPN-812" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "Indago Research & Health Center, Inc" are 64 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Indago Research & Health Center, Inc". undefined are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Indago Research & Health Center, Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Indago Research & Health Center, Inc, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".